Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 4
2010 1
2011 1
2012 1
2013 2
2014 4
2015 2
2016 3
2017 1
2018 3
2019 5
2020 5
2021 5
2022 6
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hanna burak (1 results)?
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial.
Yuen MF, Asselah T, Jacobson IM, Brunetto MR, Janssen HLA, Takehara T, Hou JL, Kakuda TN, Lambrecht T, Beumont M, Kalmeijer R, Guinard-Azadian C, Mayer C, Jezorwski J, Verbinnen T, Lenz O, Shukla U, Biermer M; REEF-1 Study Group. Yuen MF, et al. Lancet Gastroenterol Hepatol. 2023 Sep;8(9):790-802. doi: 10.1016/S2468-1253(23)00148-6. Epub 2023 Jul 10. Lancet Gastroenterol Hepatol. 2023. PMID: 37442152 Clinical Trial.
HCV Genotype Has No Influence on the Incidence of Diabetes-EpiTer Multicentre Study.
Rajewski P, Zarębska-Michaluk D, Janczewska E, Gietka A, Mazur W, Tudrujek-Zdunek M, Tomasiewicz K, Belica-Wdowik T, Baka-Ćwierz B, Dybowska D, Halota W, Lorenc B, Sitko M, Garlicki A, Berak H, Horban A, Orłowska I, Simon K, Socha Ł, Wawrzynowicz-Syczewska M, Jaroszewicz J, Deroń Z, Czauż-Andrzejuk A, Citko J, Krygier R, Piekarska A, Laurans Ł, Dobracki W, Białkowska J, Tronina O, Wietlicka-Piszcz M, Pawłowska M, Flisiak R. Rajewski P, et al. Among authors: berak h. J Clin Med. 2022 Jan 13;11(2):379. doi: 10.3390/jcm11020379. J Clin Med. 2022. PMID: 35054072 Free PMC article.
Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens.
Tronina O, Brzdęk M, Zarębska-Michaluk D, Dybowska D, Lorenc B, Janczewska E, Mazur W, Parfieniuk-Kowerda A, Piekarska A, Krygier R, Klapaczyński J, Berak H, Jaroszewicz J, Garlicki A, Tomasiewicz K, Citko J, Flisiak R. Tronina O, et al. Among authors: berak h. Viruses. 2023 Mar 4;15(3):677. doi: 10.3390/v15030677. Viruses. 2023. PMID: 36992388 Free PMC article.
Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients.
Zarębska-Michaluk D, Brzdęk M, Jaroszewicz J, Tudrujek-Zdunek M, Lorenc B, Klapaczyński J, Mazur W, Kazek A, Sitko M, Berak H, Janocha-Litwin J, Dybowska D, Supronowicz Ł, Krygier R, Citko J, Piekarska A, Flisiak R. Zarębska-Michaluk D, et al. Among authors: berak h. World J Gastroenterol. 2022 Dec 7;28(45):6380-6396. doi: 10.3748/wjg.v28.i45.6380. World J Gastroenterol. 2022. PMID: 36533109 Free PMC article.
Five-Year Follow-Up of Cured HCV Patients under Real-World Interferon-Free Therapy.
Flisiak R, Zarębska-Michaluk D, Janczewska E, Łapiński T, Rogalska M, Karpińska E, Mikuła T, Bolewska B, Białkowska J, Flejscher-Stępniewska K, Tomasiewicz K, Karwowska K, Pazgan-Simon M, Piekarska A, Berak H, Tronina O, Garlicki A, Jaroszewicz J. Flisiak R, et al. Among authors: berak h. Cancers (Basel). 2021 Jul 22;13(15):3694. doi: 10.3390/cancers13153694. Cancers (Basel). 2021. PMID: 34359594 Free PMC article.
Pangenotypic triple versus double therapy in HCV-infected patients after prior failure of direct-acting antivirals.
Flisiak R, Zarębska-Michaluk D, Berak H, Dybowska D, Sitko M, Parfieniuk-Kowerda A, Janocha-Litwin J, Janczewska E, Piekarska A, Lorenc B, Mazur W, Dobrowolska K, Tudrujek-Zdunek M, Klapaczyński J, Jaroszewicz J. Flisiak R, et al. Among authors: berak h. Clin Exp Hepatol. 2023 Sep;9(3):193-201. doi: 10.5114/ceh.2023.130935. Epub 2023 Sep 3. Clin Exp Hepatol. 2023. PMID: 37790681 Free PMC article.
Does a detectable HCV RNA at the end of DAA therapy herald treatment failure?
Zarębska-Michaluk D, Flisiak R, Janczewska E, Berak H, Mazur W, Janocha-Litwin J, Krygier R, Dobracka B, Jaroszewicz J, Parfieniuk-Kowerda A, Dobrowolska K, Rzymski P. Zarębska-Michaluk D, et al. Among authors: berak h. Antiviral Res. 2023 Dec;220:105742. doi: 10.1016/j.antiviral.2023.105742. Epub 2023 Nov 7. Antiviral Res. 2023. PMID: 37944825 Free article.
Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders.
Dybowska D, Zarębska-Michaluk D, Rzymski P, Berak H, Lorenc B, Sitko M, Dybowski M, Mazur W, Tudrujek-Zdunek M, Janocha-Litwin J, Janczewska E, Klapaczyński J, Parfieniuk-Kowerda A, Piekarska A, Sobala-Szczygieł B, Dobrowolska K, Pawłowska M, Flisiak R. Dybowska D, et al. Among authors: berak h. World J Gastroenterol. 2023 Jul 7;29(25):4085-4098. doi: 10.3748/wjg.v29.i25.4085. World J Gastroenterol. 2023. PMID: 37476581 Free PMC article.
54 results